EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer’s disease (AD): A systematic review and meta-analysis

Parnian Shobeiri iD, Sanam Alilou, Mehran Jaberinezhad iD, Farshad Zare, Nastaran Karimi, Saba Maleki, Antonio L Teixeira, George Perry, Nima Rezaei iD

PLOS ONE · 22.03.2023 · 18 (3) · e0281784

DOI: 10.1371/journal.pone.0281784 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift PLOS ONE, online erschienen am 22.03.2023. Verfasst von Parnian Shobeiri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Children's Medical Center Hospital, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran. Hauptthemen laut MEDLINE: Alzheimer Disease, RNA, Long Noncoding. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long non-coding RNAs (lncRNAs) have been reported to be involved in the pathogenesis of neurodegenerative diseases. It has also been hypothesized that plasma exosomal lncRNAs may be used as Alzheimer’s disease (AD) biomarkers. In this systematic review, we compiled all studies on the subject to evaluate the accuracy of lncRNAs in identifying AD cases through meta-analysis.

Methods

A PRISMA-compliant systematic search was conducted in PubMed/MEDLINE, EMBASE, and Web of Science databases for English publications till September 2022. We included all observational studies published which investigated the sensitivity and specificity of various lncRNAs in plasma samples of AD diagnosis. Our search strategy included lncRNA and all the related spelling and abbreviation variations combined with the keyword Alzheimer’s disease. Methodological quality was assessed using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines and the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-II) tool. The meta-analysis was carried out using the area under the Receiver Operator Characteristic (ROC) curves (AUC) and sensitivity and specificity values to assess the accuracy of the identified lncRNAs in AD diagnosis. To account for the predicted heterogeneity of the study, a random-effects model was used. All the statistical analyses and visualizations were conducted using Stata 17.0 software.

Results

A total of seven studies (AD patients = 553, healthy controls = 513) were included in the meta-analysis. Three lncRNAs were upregulated (RNA BACE-AS1, RNA NEAT1, RNA GAS5), and one lncRNA (MALAT1) was downregulated in plasma samples of AD patients. RNA 51A and RNA BC200 were reported to have variable expression patterns. A lncRNA (RNA 17A) was not significantly different between AD and control groups. The pooled sensitivity, specificity, and AUC values of lncRNAs in identifying AD were (0.74; 95% CI [0.63, 0.82], I2 = 79.2%), (0.88; 95% CI [0.75, 0.94], I2 = 88.9%), and 0.86; 95% CI [0.82, 0.88], respectively. In addition, the pooled diagnostic odds ratio (DOR) of the five individual lncRNAs in AD diagnosis was 20. Conclusion lncRNAs had high accuracy in identifying AD and must be seen as a promising diagnostic biomarker of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseRNA, Long NoncodingHumansBiomarkersSensitivity and SpecificityObservational Studies as Topic

Substanzen

BiomarkersRNA, Long Noncoding

Autor:innen und Institutionen

  • Children's Medical Center Hospital, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Clinical Research Development Unit of Tabriz Valiasr Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.

ORCID-Profile: Parnian Shobeiri, Mehran Jaberinezhad, Nima Rezaei

Zitieren

APA

Shobeiri, P., Alilou, S., Jaberinezhad, M., Zare, F., Karimi, N., Maleki, S., Teixeira, A. L., Perry, G., & Rezaei, N. (2023). Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer’s disease (AD): A systematic review and meta-analysis. PLOS ONE, 18(3), e0281784. https://doi.org/10.1371/journal.pone.0281784

Vancouver

Shobeiri P, Alilou S, Jaberinezhad M, Zare F, Karimi N, Maleki S, et al. Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer’s disease (AD): A systematic review and meta-analysis. PLOS ONE. 2023;18(3):e0281784. doi:10.1371/journal.pone.0281784

BibTeX
@article{Shobeiri2023,
  author = {Shobeiri, Parnian and Alilou, Sanam and Jaberinezhad, Mehran and Zare, Farshad and Karimi, Nastaran and Maleki, Saba and Teixeira, Antonio L and Perry, George and Rezaei, Nima},
  title = {Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer’s disease (AD): A systematic review and meta-analysis},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {3},
  pages = {e0281784},
  doi = {10.1371/journal.pone.0281784}
}
Kostenlos starten →